
03 Nov 2022
Creo powers robotic innovation
Creo Medical Group PLC develops and sells surgical devices for minimally invasive endoscopic surgery (flexible tubes mostly used in bowel procedures). In recent developments, Creo's devices and technologies are also increasingly being licensed to robotic surgery companies. These use rigid (laparosc

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Creo powers robotic innovation
Creo Medical Group Plc (CREO:LON) | 10.2 0 1.0% | Mkt Cap: 42.3m
- Published:
03 Nov 2022 -
Author:
John Savin PhD | Daniel Appiah -
Pages:
5 -
Creo Medical Group PLC develops and sells surgical devices for minimally invasive endoscopic surgery (flexible tubes mostly used in bowel procedures). In recent developments, Creo's devices and technologies are also increasingly being licensed to robotic surgery companies. These use rigid (laparosc